Literature DB >> 3491684

Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid.

D H Edwards, T M Griffith, H C Ryley, A H Henderson.   

Abstract

Endothelium dependent relaxation of isometrically mounted rabbit aortic strip preparations was rapidly inhibited by human plasma at dilutions down to 1:1000. Gel filtration and ion exchange chromatography were used to demonstrate that this inhibitory activity was present in fractions containing haptoglobin. Purified haptoglobin itself possessed no inhibitory action against endothelium dependent relaxation, but the haptoglobin-haemoglobin complex did, consistent with the documented ability of haemoglobin to inhibit this phenomenon. The concentration of haemoglobin normally bound to haptoglobin is sufficient to account for the inhibitory properties of human plasma. This suggests that endothelium derived relaxing factor exerts no downstream intravascular effect in vivo and thus that its physiological dilator role is that of a local autocoid acting on subjacent smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491684     DOI: 10.1093/cvr/20.8.549

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  23 in total

Review 1.  Endothelial regulation of vascular tone.

Authors:  P Vallance
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

Review 2.  St Cyres lecture. Endothelium in control.

Authors:  A H Henderson
Journal:  Br Heart J       Date:  1991-03

3.  Hyperkalemia in a patient with rhabdomyolysis and compartment syndrome -A case report-.

Authors:  Soon Eun Park; Dae-Young Kim; Eun-Sun Park
Journal:  Korean J Anesthesiol       Date:  2010-12-31

4.  Endothelium in control.

Authors:  C Borland
Journal:  Br Heart J       Date:  1991-11

5.  Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.

Authors:  Peter C Minneci; Katherine J Deans; Huang Zhi; Peter S T Yuen; Robert A Star; Steven M Banks; Alan N Schechter; Charles Natanson; Mark T Gladwin; Steven B Solomon
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

6.  EDRF-mediated dilatation in the rat isolated perfused kidney: a microangiographic study.

Authors:  G A Burton; T M Griffith; D H Edwards
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

7.  Endothelium-derived relaxing factor (EDRF) and resistance vessels in an intact vascular bed: a microangiographic study of the rabbit isolated ear.

Authors:  T M Griffith; D H Edwards; R L Davies; T J Harrison; K T Evans
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

8.  Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.

Authors:  S M Yu; Z J Cheng; J H Guh; F Y Lee; S C Kuo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

9.  Biological activity of nitric oxide in the plasmatic compartment.

Authors:  Xunde Wang; Jose E Tanus-Santos; Christopher D Reiter; Andre Dejam; Sruti Shiva; Reginald D Smith; Neil Hogg; Mark T Gladwin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

10.  The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man.

Authors:  P Vallance; N Benjamin; J Collier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.